Clinical trials recruiting in Itzehoe, Germany

Phase breakdown

Conditions recruiting in Itzehoe, Germany

Recruiting trials in Itzehoe, Germany

• A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
  NCT05344469 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• A Non-interventional, Prospective Study With Benralizumab
  NCT06422078 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
  NCT07225504 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions
  NCT07052396 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• The CATALINA Study
  NCT05008081 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Itzehoe, Germany?

6 recruiting trials have at least one study site in Itzehoe, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.